Paragon Care Limited PXS.F Stock
Paragon Care Limited Price Chart
Paragon Care Limited PXS.F Financial and Trading Overview
Paragon Care Limited stock price | 0.18 EUR |
Previous Close | 0.13 EUR |
Open | 0.14 EUR |
Bid | 0.14 EUR x 2000000 |
Ask | 0.16 EUR x 2000000 |
Day's Range | 0.14 - 0.14 EUR |
52 Week Range | 0.13 - 0.28 EUR |
Volume | 575 EUR |
Avg. Volume | 0 EUR |
Market Cap | 97.12M EUR |
Beta (5Y Monthly) | 1.237547 |
PE Ratio (TTM) | Infinity |
EPS (TTM) | 0.01 EUR |
Forward Dividend & Yield | 0.01 (5.55%) |
Ex-Dividend Date | March 14, 2023 |
1y Target Est | N/A |
PXS.F Valuation Measures
Enterprise Value | 202.79M EUR |
Trailing P/E | Infinity |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.3343347 |
Price/Book (mrq) | 0.3678474 |
Enterprise Value/Revenue | 0.698 |
Enterprise Value/EBITDA | 11.086 |
Trading Information
Paragon Care Limited Stock Price History
Beta (5Y Monthly) | 1.237547 |
52-Week Change | -25.40% |
S&P500 52-Week Change | 20.43% |
52 Week High | 0.28 EUR |
52 Week Low | 0.13 EUR |
50-Day Moving Average | 0.14 EUR |
200-Day Moving Average | 0.18 EUR |
PXS.F Share Statistics
Avg. Volume (3 month) | 0 EUR |
Avg. Daily Volume (10-Days) | 0 EUR |
Shares Outstanding | 659.35M |
Float | 386.48M |
Short Ratio | N/A |
% Held by Insiders | 41.84% |
% Held by Institutions | 4.20% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0.016 |
Trailing Annual Dividend Yield | 12.03% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 1.6667 |
Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | June 30, 2022 |
Most Recent Quarter (mrq) | December 31, 2022 |
Next Fiscal Year End | June 30, 2023 |
Profitability
Profit Margin | 2.28% |
Operating Margin (ttm) | 5.11% |
Gross Margin | 39.52% |
EBITDA Margin | 6.29% |
Management Effectiveness
Return on Assets (ttm) | 2.53% |
Return on Equity (ttm) | 4.48% |
Income Statement
Revenue (ttm) | 290.49M EUR |
Revenue Per Share (ttm) | 0.48 EUR |
Quarterly Revenue Growth (yoy) | 38.29% |
Gross Profit (ttm) | 98.23M EUR |
EBITDA | 18.29M EUR |
Net Income Avi to Common (ttm) | 6.64M EUR |
Diluted EPS (ttm) | 0 |
Quarterly Earnings Growth (yoy) | 0.10% |
Balance Sheet
Total Cash (mrq) | 26.67M EUR |
Total Cash Per Share (mrq) | 0.04 EUR |
Total Debt (mrq) | 131.09M EUR |
Total Debt/Equity (mrq) | 52.69 EUR |
Current Ratio (mrq) | 1.446 |
Book Value Per Share (mrq) | 0.367 |
Cash Flow Statement
Operating Cash Flow (ttm) | 16.35M EUR |
Levered Free Cash Flow (ttm) | -10218250 EUR |
Profile of Paragon Care Limited
Country | Germany |
State | VIC |
City | Mt Waverley |
Address | 77-97 Ricketts Road |
ZIP | 3149 |
Phone | 61 3 8833 7800 |
Website | https://www.paragoncare.com.au |
Industry | Medical Distribution |
Sector(s) | Healthcare |
Full Time Employees | N/A |
Paragon Care Limited supplies durable medical equipment, medical devices, and consumable medical products to health and aged care markets in Australia, New Zealand, and internationally. The company offers clinical solutions for anaesthetists, intensivists, cardiac, vascular, and pain management; designs, manufactures, and distributes reagent red blood cells, monoclonal blood grouping reagents, and ancillary products for immunohaematology laboratories; and eye care products, such as ophthalmology and optometry, neonatal vision screening, and procedural kits. It also provides neonatal and paediatric assessment and treatment, including newborn hearing and vision screening, jaundice management, targeted temperature management, cerebral function monitoring, and seizure detection, as well as pain management and enteral feeding solutions; surgical products for hip and knee arthroplasty, infection prevention, pain management, biologics, and the operating room; and equipment repair and maintenance services. In addition, the company offers sterilisable transducers for surgical procedures such as neurology, hepatobiliary, renal, colorectal, vascular, laparoscopic, and robotic procedures; ultrasound systems, shockwave therapy, lasers, and accessories for infection control; and veterinary products, including point-of-care diagnostics, therapeutic lasers, oncology delivery products, centrifuges, autoclaves, IV lines and fluid therapy products, wearable CRI systems, and IT Solutions. Further, it provides telephony, nurse call, access control, CCTV, cordless, and Wi-Fi products. The company was formerly known as Citrofresh International Limited and changed its name to Paragon Care Limited in June 2008. Paragon Care Limited was incorporated in 1994 and is based in Mt Waverley, Australia.
Q&A For Paragon Care Limited Stock
What is a current PXS.F stock price?
Paragon Care Limited PXS.F stock price today per share is 0.18 EUR.
How to purchase Paragon Care Limited stock?
You can buy PXS.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Paragon Care Limited?
The stock symbol or ticker of Paragon Care Limited is PXS.F.
Which industry does the Paragon Care Limited company belong to?
The Paragon Care Limited industry is Medical Distribution.
How many shares does Paragon Care Limited have in circulation?
The max supply of Paragon Care Limited shares is 734.29M.
What is Paragon Care Limited Price to Earnings Ratio (PE Ratio)?
Paragon Care Limited PE Ratio is 18.30000100 now.
What was Paragon Care Limited earnings per share over the trailing 12 months (TTM)?
Paragon Care Limited EPS is 0.01 EUR over the trailing 12 months.
Which sector does the Paragon Care Limited company belong to?
The Paragon Care Limited sector is Healthcare.